19-Hydroxyeicosatetraenoic acid and isoniazid protect against angiotensin II-induced cardiac hypertrophy
- 1 December 2015
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 289 (3) , 550-559
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research (CIHR) (106665)
This publication has 31 references indexed in Scilit:
- Heart Disease and Stroke Statistics—2012 UpdateCirculation, 2012
- Cytochrome P450 1B1 Contributes to Angiotensin II–Induced Hypertension and Associated PathophysiologyHypertension, 2010
- Alteration of cardiac cytochrome P450-mediated arachidonic acid metabolism in response to lipopolysaccharide-induced acute systemic inflammationPharmacological Research, 2010
- Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophyProceedings of the National Academy of Sciences, 2009
- Modulation of Cytochrome P450 Gene Expression and Arachidonic Acid Metabolism during Isoproterenol-Induced Cardiac Hypertrophy in RatsDrug Metabolism and Disposition, 2008
- 20-Hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncouplingAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programmeHeart, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Inhibition of Cytochrome P450 (CYP450) Isoforms by Isoniazid: Potent Inhibition of CYP2C19 and CYP3AAntimicrobial Agents and Chemotherapy, 2001
- Arachidonic acid interaction with the mitochondrial electron transport chain promotes reactive oxygen species generationFree Radical Biology and Medicine, 1999